Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study
- 1 December 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Infection
- Vol. 81 (6), 961-965
- https://doi.org/10.1016/j.jinf.2020.11.012
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Contributes to Ischemic Stroke Risk: A Meta-Analysis of 50 Case-Control StudiesPLOS ONE, 2012
- Meta‐analysis of the relationship between ACE I/D gene polymorphism and end‐stage renal disease in patients with diabetic nephropathyNephrology, 2012
- Review: Association between angiotensin converting enzyme G2350A polymorphism and hypertension risk: a meta-analysisJournal of the Renin-Angiotensin-Aldosterone System, 2010
- The geographic distribution of the ACE II genotype: a novel findingGenetics Research, 2007
- Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome*Critical Care Medicine, 2006
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- PART 1: Executive Summary of Disease Management of Drug Hypersensitivity: A Practice ParameterAnnals of Allergy, Asthma & Immunology, 1999
- Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.JCI Insight, 1997
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990
- Compared Evolution of Plasma Fibronectin and Angiotensin-converting Enzyme Levels in Septic ARDSChest, 1985